Form 4: Clene Inc. Director Matthew Kiernan Acquires Stock Options
SEC Form 4
Director Matthew Kiernan was granted stock options for 29,481 shares of Clene Inc. common stock on March 11, 2024.
Summary
- On March 11, 2024, Matthew Kiernan, a director of Clene Inc., was granted stock options to purchase 29,481 shares of the company's common stock.
- The options were granted under the Clene Inc. Amended 2020 Stock Plan.
- The exercise price for the options is $0.44 per share.
- The options vest immediately upon grant and expire on March 11, 2034.
Sentiment
Score: 5
Explanation: Neutral. This is a routine disclosure of stock option grants to a company director.
Positives
- The immediate vesting of the options could incentivize the director to work towards the company's success.
Future Outlook
NA
Industry Context
This is a standard Form 4 filing, reflecting a director's acquisition of stock options, a common practice in corporate compensation.
Stakeholder Impact
- The granting of stock options to a director can align their interests with those of shareholders, potentially leading to increased company value.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Date of transaction: Matthew Kiernan was granted stock options for 29,481 shares of Clene Inc. common stock. |
| 03/11/2034 | Expiration date of the stock options. |
| 03/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.